1. Introduction {#s0005}
===============

The gold standard for diagnosing syncope is to elucidate the symptom-electrocardiograph (ECG) correlation. ECG monitoring is an established procedure in the evaluation and monitoring of patients with syncope. The ECG recordings during syncope allow physicians to confirm or exclude an arrhythmia as the mechanism of syncope. Many studies have investigated the use of internal loop recorder (ILR), while there are few studies of external loop recorder (ELR) for patients with unexplained syncope. However, there is still some uncertainty in their clinical utility and practical approach. The aim of this review is to clarify the clinical usefulness of ILR and ELR in the diagnosis and management of patients with unexplained syncope.

2. Internal loop recorders {#s0010}
==========================

ILRs were developed in the early 1990s. They have a battery life of approximately 3 years and are able to record an ECG signal from small leads on either end of the device. Cardiac events can be detected manually or automatically and are saved on the device for up to 40 minutes. Since September 2016, ILR has been downsized. It is expected that the chances of using ILR will increase. Although ILR is used for patients with unexplained syncope, ILR research examines the following viewpoints: 1. Early diagnosis of unexplained syncope, 2. Mortality in patients with ILR, 3. Quality of life in patients with ILR, 4. Cost effectiveness, 5. Adverse effects of ILR, 6. When should we use ILR?

2.1. Early diagnosis of unexplained syncope {#s0015}
-------------------------------------------

Many observational and four randomized control studies have investigated the use of the ILR [@bib1]. The diagnostic yield of the ILR is higher than conventional testing, mainly due to prolonged monitoring periods [@bib2], [@bib3], [@bib4]. ILR achieved a more rapid diagnosis in unexplained syncope than conventional techniques [@bib5]. The Randomized Assessment of Syncope Trial (RAST) study randomized 60 patients to either conventional investigation with an ELR for 2--4 weeks, an electrophysiological testing, and a tilt-table test, or a prolonged monitoring for 1 year with an ILR. This study suggested that early implantation with ILR was more effective (52% diagnosed versus 20%) compared to the conventional strategy [@bib2]. An ILR-guided diagnosis was demonstrated in 78% of 570 patients with pre-syncope or syncope during an average follow-up of 10 months in the multinational Place of Reveal in the Care Pathway and Treatment of Patients with Unexplained Recurrent Syncope Registry (PICTURE registry) [@bib6]. In a meta-analysis, Solbiati reported on the diagnosis of ILR using four randomized control trials ([Fig. 1](#f0005){ref-type="fig"}). There was a significant difference in the number of diagnoses between patients who received ILR and those who were managed conventionally at a long-term follow-up [@bib7]. In selected patients, the symptom-ECG correlation was as high as 88%, and the diagnostic value increased with increasing observation time [@bib8], [@bib9]. Studies on ILR have also provided the important details of the mechanism and treatment strategy of syncope [@bib10], [@bib11], [@bib12], [@bib13], [@bib14]. There are fewer papers regarding ILR for patients with unexplained syncope in Japan [@bib15], [@bib16], [@bib17]. Onuki demonstrated that the estimated diagnostic rates of ILR for unexplained syncope were 47% and 65% at 1 and 2 years, respectively, in a single center retrospective observational study ([Fig. 2](#f0010){ref-type="fig"}). They also presented that the symptom-free rate of patients with ILR and patients with conventional investigation was approximately the same ([Fig. 3](#f0015){ref-type="fig"}). This means that the ILR does not have any effect on occurrence of the unexplained syncope [@bib16]. Additionally, the ILR provides information about the characteristics of the heart rhythm during syncope in patients with neutrally mediated reflex syncope, and it may help guide decisions regarding specific therapy [@bib18], [@bib19], [@bib20].Fig. 1Forest plot of comparison of ILR vs Standard Assessment. (Quoted from Solbiat M et al. [@bib7]).Fig. 1.Fig. 2Cumulative diagnostic rates between the use of an ILR and conventional tests. (Quoted from Onuki et al. [@bib16]).Fig. 2.Fig. 3Symptom-free survival curve for the use of an ILR and conventional tests. (Quoted from Onuki et al. [@bib16]).Fig. 3.

2.2. Mortality and ILR {#s0020}
----------------------

There is no research on ILR that evaluates life prognosis improvement as a primary endpoint. Only two studies reported data on mortality at one year and 18 months [@bib2], [@bib3]. There was no evidence of a difference in the risk of mortality between patients with ILR and those who were managed conventionally at follow-up.

2.3. Quality of Life and ILR {#s0025}
----------------------------

Two studies analyzed quality of life in patients with ILR. Farwell measured quality of life using the Medical Outcomes Questionnaire (SF-12) and a visual analogue scale (VAS) at induction, 6, 12, and 18 months. They reported that there was a trend towards improved quality of life in the ILR group compared to the control group. Additionally, there were significant increases observed in VAS at 18 months, and no changes were noted in SF-12 scores. They discussed that the earlier use of appropriate therapeutic interventions using ILR significantly decreasing subsequent syncope, which may reflect improved quality of life [@bib3]. Podopleanu performed an analysis of quality of life using the 36-Item Short Form Health Survey (SF-36) questionnaire at baseline, 6 months, and after 14 months of follow-up. There was no difference between the ILR group and the control group in terms of quality of life main composite score, suggesting general physical and psychological well-being [@bib4].

2.4. Cost effectiveness {#s0030}
-----------------------

Two studies analyzed the cost-effectiveness of using ILR or conventional management as diagnostic tools. The RAST study suggested that early intervention with ILR was more cost-effective than the conventional strategy, which includes ELR for 2--4 weeks, electrophysiological testing, and tilt-table testing [@bib2]. Krahn calculated the cost of investigation based on the Ontario Health Insurance Program fee schedule for technical and professional fees, and also included an estimate of materials, labor, maintenance, and overhead costs for hospital-based investigations. The mean cost of ILR as the primary monitoring strategy was greater than that of the conventional strategy, but the cost of ILR monitoring per diagnosis was less than that of the conventional strategy. Farwell reported that overall mean costs were lower in the ILR group than in the conventional management group without statistical significance [@bib3]. Length of follow-up might influence costs, as ILR may be more costly initially, but it might be balanced by a lower need for tests and hospitalization in the long term.

2.5. Adverse effects and disadvantages of the ILR {#s0035}
-------------------------------------------------

ILRs carry the risk of pocket infections that resolve with device explanation. This complication, which can occur either in the peri-procedural phase or later during the follow-up, was reported in 1 to 5% of patients. Another disadvantage of ILR includes the presence of under-sensing or over-sensing. This is due to the difficulty of distinguishing between SVT and VT, and the ambiguous P wave [@bib13], [@bib21].

2.6. When should we use ILR? {#s0040}
----------------------------

Current *European Society of Cardiology Guidelines* recommend ILR-implantation at an early stage in patients with unexplained syncope without high-risk criteria based on efficacy, safety, and cost-utility [@bib1], [@bib22]. After initial evaluation (detailed history, physical examination, and orthostatic challenging ECG) for patients with unknown syncope, an arrhythmic cause is suspected, but the likelihood for recurrence is low. Therefore, early use of ILR is recommended [@bib23]. The initial evaluations can provide the diagnosis in up to 50% of the cases [@bib24], [@bib25]. When the diagnosis is made, no further testing is needed and appropriate therapy can be initiated. For the remaining cases, the risk assessment and suspected etiology of the syncope determines the further diagnostic approach ([Fig. 4](#f0020){ref-type="fig"}).Fig. 4The use of ECG monitoring in the work-up of syncope. (Quoted from Ruwald and Zareba [@bib23]).Fig. 4.

3. External loop recorder {#s0045}
=========================

There are a few studies using ELR for patients with unknown syncope. The diagnostic yield of ELR was higher than standard 24h-Holter monitoring [@bib24], and it was similar to the diagnostic yield of ILR in the same timeframe [@bib25], [@bib26], [@bib27]. The limitations of ELR are patient compliance, failure to operate the device correctly, and difficulties handling cutaneous patch electrodes [@bib26]. A cost-effectiveness analysis has indicated that the improvement in diagnostic yield offsets the cost of the ELR and that they are an economically attractive alternative when compared to Holter monitoring [@bib28]. The use of ELR could be viewed as a first-choice tool for patients with early recurrence of syncope [@bib23].

4. Conclusion {#s0050}
=============

ILR is useful as tool for early diagnosis and improving diagnosis rate for patients with unknown syncope. ILR also provides important information on syncope mechanism and treatment strategy. However, there is no evidence of improvement of total mortality and quality of life while using ILR. The diagnostic yield of ELR in patients with syncope was similar to ILR within the same timeframe. Therefore, ELR could be considered for patients for long-term ECG monitoring before ILR.
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